Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(23 sites)
Belgium
Universitair Ziekenhuis Gent, Ghent Czechia
Fakultni nemocnice v Motole, Prague France
Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron Hopital Armand Trousseau, Paris Germany
Kindernierenzentrum Bonn, Bonn Universitaetsklinikum Koeln, Cologne Universitaetsklinikum Hamburg Eppendorf, Hamburg Medizinische Hochschule Hannover, Hanover Universitaetsklinikum Heidelberg, Zentrum fuer Kinder und Jugendmedizin, Heidelberg Greece
General Children Hospital Panagioti and Aglaias Kyriakou, Athens Ippokrateio General Hospital of Thessaloniki, Thessaloniki Hungary
Semmelweis Egyetem, Budapest Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged Italy
Azienda Ospedaliera Universitaria Meyer, Florence Lithuania
Childrens Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilinus Poland
Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow Portugal
Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio, Porto Spain
Hospital Universitario Virgen del Rocio, Seville, Andalusia Hospital Universitari Vall d Hebron, Barcelona, Catalonia United Kingdom
Royal Hospital for Sick Children, Glasgow Leeds Teaching Hospitals NHS Trust, Leeds Great Ormond Street Hospital for Children, London University Hospital Southampton NHS Foundation Trust, Southampton